Hepatitis B virus-associated cryoglobulinaemia diffuse endocapillary proliferative glomerulonephritis: a case report and literature review.
Xu W, Han Y.
J Int Med Res. 2022 Nov;50(11):3000605221131136. doi: 10.1177/03000605221131136.
Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease.
Cacoub P, Asselah T.
Am J Gastroenterol. 2022 Feb 1;117(2):253-263. doi: 10.14309/ajg.0000000000001575.
Polyarteritis Nodosa: Old Disease, New Etiologies.
Wolff L, Horisberger A, Moi L, Karampetsou MP, Comte D.
Int J Mol Sci. 2023 Nov 23;24(23):16668. doi: 10.3390/ijms242316668.
Hepatitis B virus-associated membranous glomerulonephropathy.
Chen A, Ho YS, Tu YC, Shieh SD, Cheng TC.
J Clin Gastroenterol. 1988 Jun;10(3):243-6.
[Virus associated glomerulonephritis].
Tillmann HL, Schwarz A.
Internist (Berl). 2003 Sep;44(9):1098-106. doi: 10.1007/s00108-003-1024-3.
Targeting hepatitis B virus-associated nephropathy: efficacy and challenges of current antiviral treatments.
Hu Y, Zhang Y, Jiang W.
Clin Exp Med. 2025 Feb 15;25(1):57. doi: 10.1007/s10238-025-01584-4.
Diagnosis and classification of polyarteritis nodosa.
Hernández-Rodríguez J, Alba MA, Prieto-González S, Cid MC.
J Autoimmun. 2014 Feb-Mar;48-49:84-9. doi: 10.1016/j.jaut.2014.01.029. Epub 2014 Jan 28.
Liver Disease-Associated Glomerulopathies.
Kanduri SR, Peleg Y, Wadhwani S.
Adv Kidney Dis Health. 2024 Mar;31(2):147-156. doi: 10.1053/j.akdh.2023.11.002.
Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.
Zhang Y, Zhou JH, Yin XL, Wang FY.
World J Gastroenterol. 2010 Feb 14;16(6):770-7. doi: 10.3748/wjg.v16.i6.770.
Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis.
Fabrizi F, Dixit V, Martin P.
Aliment Pharmacol Ther. 2006 Sep 1;24(5):781-8. doi: 10.1111/j.1365-2036.2006.03041.x.
